Hypertens Res
No. 3 p.237-242 Original Article
Pulse Wave Velocity as a Marker of Arteriosclerosis and Its Comorbidities in Chinese Patients
Xiao-Ning LIU 1) , Hai-Qing GAO 1) , Bao-Ying LI 1) , Mei CHENG 1) , Ya-Bing MA 1) , Zhi-Mian ZHANG 2) , Xi-Mei GAO 2) , Yuan-Ping LIU 1) , and Min WANG 1) To obtain reliable data on the epidemiology of arteriosclerosis and the comorbidities in patients with hypertension (HP), coronary heart disease (CHD) 
Introduction
Arteriosclerotic diseases are a main cause of mortality worldwide. Coronary heart disease (CHD) and stroke are important manifestations of systemic atherosclerosis. Moreover, arteriosclerosis leads to the degeneration of arterial elasticity. Elasticity is an important characteristic of the arteries and is a direct reflection of their condition (1) . It has been reported that pulse wave velocity (PWV) is an independent predictor of cardiovascular and cerebrovascular mortality in hypertensive patients (2) . The aims of the present study were to evaluate the relationship between PWV and hypertension (HP), CHD, type 2 diabetes mellitus (T2DM) and stroke, and to determine whether noninvasive measurement of PWV can be a useful approach to screening Chinese patients who are at high risk for generalized arteriosclerosis. ; in all cases, the diagnoses were made no later than 1999. As for the healthy volunteers, selection criteria were generated before the trial began, based on the records of participating health care providers. The inclusion criteria were general good health and mobility and agreement to conform with the trial guidelines or provide notification of noncompliance. They had no medical history of atherogenic diseases, cardiovascular diseases, renal insufficiency or other diseases requiring medical treatment. A "healthy subject" was defined by the following criteria: blood pressure < 140/90 mmHg, fasting blood glucose < 110 mg/dl, total cholesterol < 240 mg/dl, triglycerides < 150 mg/dl, uric acid < 7.5 mg/dl, body mass index (BMI) < 25 kg/m 2 , and no history of smoking. Exclusion criteria were any recent history of acute or chronic debilitating illness or any record of HP, DM, CHD, stroke, peripheral vascular disease or hyperlipemia, according to the 1999 WHO diagnostic guidelines. All subjects gave informed written consent. All subjects and all clinical data were collected cross-sectionally from medical records. The study protocol was approved by the Ethics Board of Qi-Lu Hospital of Shandong University.
Methods

Subjects
Medical History and Examinations
All participants were administered a standardized questionnaire that obtained information about their occupation, medical history, drug use, smoking, personal habits, and family medical histories. Risk factors included obesity, HP, T2DM, CHD and stroke. The subjects' weight and height were measured while they were wearing light clothes without shoes. BMI was calculated as the weight in kg divided by the square of the height in m.
Hypertension was defined as a systolic blood pressure (SBP) of ≥ 140 mmHg, a diastolic blood pressure (DBP) of ≥ 90 mmHg or the current use of antihypertensive drugs (according to 1999 WHO criteria). T2DM was diagnosed by 1) a fasting plasma glucose concentration of > 7.0 mmol/l in the absence of treatment; 2) a plasma glucose concentration of ≥ 11.0 mmol/l, 2 h after a 75 g oral glucose load; or 3) current treatment with glucose-lowering drugs. None of the subjects had a history of ketoacidosis. The presence of underlying CHD was defined as a history of a physician-diagnosed heart attack, evidence of prior myocardial infarction by electrocardiogram or self-reporting of a prior coronary revascularization procedure (percutaneous coronary artery intervention [PCI] or coronary-artery bypass surgery [CABG] ).
PWV Measurement
Carotid-femoral PWV was measured in a temperature-controlled room at 24°C. This method, including the use of an automatic device (Complior, Artech, France) has been extensively applied. Briefly, two pressure waves were recorded transcutaneously at the base of the neck for the right common carotid artery and over the right femoral artery. PWV was determined as the foot-to-foot velocity. Pulse transit time was determined as the average of 10 consecutive beats. The distance traveled by the pulse wave was measured over the body surface as the distance between the two recording sites. Aortic PWV was calculated as the ratio of distance to transit time. The validation of this automatic method and its reproducibility have been previously published, with an intraobserver repeatability coefficient of 0.93 and an interobserver reproducibility coefficient of 0.89 (3) (4) (5) . R. Asmar proposed a PWV cutoff level of 12 m/s at the 15th Great Wall International Congress of Cardiology. Subjects were assigned to one of two groups according to their PWV level, as follows: PWV ≥ 12 m/s and PWV < 12 m/s.
Statistical Analysis
All data were analyzed by SPSS 10.0 for Windows (SPSS, Chicago, USA). Continuous variables were given as means±SD. The variables included in the analysis were age, gender, BMI, and the presence of HP, T2DM, CHD and Table 1 shows the baseline characteristics of the healthy subjects and the patients. Age, BMI and heart rate showed no significant difference (p> 0.05) between the groups, but the patients had higher blood pressure (p< 0.001). The PWV values are shown in Table 3 lists the baseline characteristics of patients with and without increased PWV, the results of the univariate analysis of arteriosclerosis and its comorbidities, and the levels of statistical significance. Of the 910 subjects were included in the study, 25.7% were female, and the mean age and mean BMI were 73.67±5.08 years and 25.21±3.08 kg/m 2 , respectively. More than half (53.7%) of the patients had HP, 20.3% had T2DM, 52.5% had CHD and 24.2% had stroke. Moreover, 613 (67.4%) of patients whose PWV ≥ 12 m/s had large artery arteriosclerosis. The mean value of PWV was 13.78±3.48 m/s in all patients, 15.41±3.03 m/s in the arteriosclerosis group and 10.41±1.28 m/s in the non-arteriosclerosis group. The difference was significant between the latter two groups. The patients with arteriosclerosis were older (74.49±4.66 years vs. 72.00±5.48 years, p< 0.05). The proportion of patients in the arteriosclerosis group with concomitant clinical HP, T2DM, CHD and stroke was also higher (Table 3) . As shown in Table 3 , CHD was present in 56.1% of patients with arteriosclerosis and 45.1% of patients without it ( p = 0.002); for stroke, these values were 26.6% vs . 19.2% ( p = 0.015); for T2DM, 24.8% vs . 11.1% ( p < 0.001); and for HP, 63.3% vs . 34.0% ( p < 0.001). After multiple logistic regression analysis, female sex, older age, HP and T2DM were risk factors for large artery arteriosclerosis. However, the OR values for CHD and stroke were not significant different ( p > 0.05).
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Discussion
This is the first large-scale study of Chinese patients with arteriosclerosis and its comorbidities. We demonstrated that a higher PWV was associated with age, female sex, BMI, HP, T2DM, CHD and stroke. Our data suggested that measurements of PWV might be useful indicators of systemic atherosclerosis in Chinese patients with cardiovascular risk factors. Previous studies ( 6 -12 ) reported that PWV could be used to predict the mortality from HP, T2DM, CHD and stroke, all of which were associated with cardiovascular events and risk factors. The results of this study are consistent with these observations.
Our study was based on relatively old outpatients; hence the results cannot be fully generalized to a large population. Nonetheless, our results clearly showed a substantial prevalence of arteriosclerosis in patients at high risk for cardiovascular disease. In this study, large artery arteriosclerosis was more prevalent in females (76.1%) than in males (64.3%), which was consistent with other studies. The reason for this sex difference is that the patients in our study were relatively old (mean age, 73.67 years old), so menopause probably contributed to atherosclerosis in females (13) (14) (15) (16) .
In our study, HP and T2DM increased the risk of large artery arteriosclerosis. Several studies have shown that the structure of a vessel changes when an increase in blood pressure augments vascular tension (6, (17) (18) (19) (20) . That is to say, with vascular smooth muscle cell hyperplasia and vessel wall thickening, diffuse fibrosclerosis and local atherosclerosis will occur in the vessel wall over the long term. Moreover, long-lived proteins (e.g., vascular collagen) undergo continual cross-linking because diabetes increases the formation of Mean±SD. PWV, pulse wave velocity; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; HR, heart rate; HP, hypertension; T2DM, type 2 diabetes mellitus; CHD, coronary heart disease. advanced glycation end products (AGEs). In the cardiovascular system, the presence of AGE cross-links within the vascular wall increases vascular stiffness (21) (22) (23) . These effects, in turn, lead to increased arterial stiffness, a quickening of PWV and the prevalence of large artery atherosclerosis. Univariate regression analysis showed that CHD and stroke were associated with large artery atherosclerosis, but logistic regression analysis showed that they were not risk factors for atherosclerosis. On the other hand, studies have reported that PWV is an independent predictor of CHD and stroke in hypertensive patients (7) (8) (9) (10) 24) . The discrepancy can be partly explained by the effects of hypertension on PWV. The relationships between PWV and both CHD and stroke need to be further studied. There were certain limitations to our study. Because this was the cross-sectional part of our investigation, we could not determine whether PWV could predict cardiovascular events. Further longitudinal studies will reveal the clinical significance of PWV.
Our study suggests that PWV might be a marker of arteriosclerosis and its comorbidities. Furthermore, non-invasive measurements such as PWV can accurately reveal cardiovascular abnormalities and might be used to screen for arteriosclerotic diseases in Chinese patients with risk factors. The prevalence of cardiovascular disease has been increasing in China due to recent changes in diet and lifestyle. Therefore, the screening for arteriosclerosis described in the present report may be particularly useful in the future. PWV measurement can be used as a routine clinical evaluation of high-risk patients. Arteriosclerotic risk factors such as HP, T2DM, CHD and stroke should be treated adequately.
